Ann: Lumos and BARDA Partnership - Investor Briefing Recording, page-3

Its good they have posted this. Provides clarity to those who didn't attend or are new to the company to fully understand the preso.

I think the key point people need to recall: $20MillionUSD in government funding specifically for this antimicrobial resistance in the entire USA. LDX has 50% of that.

Again, rehashing this - AT1 rose over 30% on the news of $43MillionAUD in AUS Government budget funding, of which AT1 got all of $1.3Million.

Lumos was just granted a non refundable $4.48MillionAUD with a further circa $7.6MillionAUD for this study.